Cholesterol absorption inhibitor and statin

This page covers all Cholesterol absorption inhibitor and statin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting NPC1L1 and HMG-CoA reductase.

Targets

NPC1L1 and HMG-CoA reductase

Phase 3 pipeline (1)

• ezetimibe with simvastatin · Organon and Co · Cardiovascular
  Ezetimibe inhibits the absorption of cholesterol in the small intestine, while simvastatin is a statin that inhibits HMG-CoA reductase, a key enzyme in cholesterol synthesis.

Patent intelligence

• cholesterol absorption inhibitor and statin patent landscape — aggregated cliff calendar, attackable patents, originator estates